Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
CymaBay Therapeutics Raises USD26.8 Million in Venture Financing 11
Partnerships 12
HistoIndex and CymaBay Therapeutics Enter into Partnership 12
Equity Offering 13
CymaBay Therapeutics Raises USD114 Million in Public Offering of Shares 13
CymaBay Therapeutics Raises USD97 Million in Public Offering of Shares 15
CymaBay Therapeutics Raises USD10 Million in Public Offering of Shares 17
CymaBay Therapeutics Raises USD0.3 Million in Private Placement of Securities 18
CymaBay Therapeutics Raises USD23 Million in Public Offering of Shares 19
CymaBay Therapeutics Raises USD25.3 Million in Public Offering of Shares 21
CymaBay Therapeutics Completes Third Tranche Of Private Placement Of Shares For US$33.2 Million 23
CymaBay Therapeutics Inc – Key Competitors 24
CymaBay Therapeutics Inc – Key Employees 25
CymaBay Therapeutics Inc – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Financial Announcements 27
Nov 06, 2018: CymaBay reports third quarter 2018 financial results and provides corporate update 27
Nov 06, 2018: Cymabay reports third quarter 2018 financial results and provides corporate update 29
Aug 09, 2018: Cymabay reports second quarter 2018 financial results and provides corporate update 31
May 08, 2018: CymaBay Reports First Quarter 2018 Financial Results and Provides Corporate Update 33
Mar 15, 2018: CymaBay Announces Fourth Quarter and Fiscal 2017 Financial Results 34
Nov 08, 2017: CymaBay Reports Third Quarter 2017 Financial Results and Corporate Updates 36
Aug 10, 2017: CymaBay Reports Second Quarter 2017 Financial Results and Provides Corporate Update 37
May 11, 2017: CymaBay Reports First Quarter 2017 Financial Results and Provides Corporate Update 39
Mar 23, 2017: CymaBay Reports Fourth Quarter and Year End 2016 Financial Results 40
Corporate Communications 41
Mar 29, 2017: CymaBay Announces the Retirement of President and Chief Executive Officer, Harold Van Wart, Ph.D. 41
Product News 42
10/31/2017: CymaBay Announces the Appointment of Sujal Shah as President and Chief Executive Officer 42
06/19/2018: CymaBay Therapeutics to Host Analyst and Investor Day on June 26, 2018 43
01/08/2018: CymaBay Therapeutics: Enrollment Begins in Long-Term Extension Study of Seladelpar in Patients with Primary Biliary Cholangitis 44
01/08/2018: CymaBay Therapeutics Receives $5 Million Milestone Payment for Arhalofenate from Kowa Pharmaceuticals America 45
Product Approvals 46
Sep 11, 2017: CymaBay Therapeutics Granted EMA Orphan Drug Designation for Seladelpar for the Treatment of Primary Biliary Cholangitis 46
Clinical Trials 47
May 08, 2018: CymaBay Therapeutics Announces the Initiation of a Phase 2b Study of Seladelpar in Patients with Non-Alcoholic Steatohepatitis 47
Apr 11, 2018: CymaBay Announces Positive New 12-Week and 26-Week Results from its Ongoing Phase 2 Study of Seladelpar in Patients with Primary Biliary Cholangitis at The International Liver Congress 2018 48
Oct 23, 2017: CymaBay to Host Post-AASLD Key Opinion Leader Meeting on Novel Treatments for Primary Biliary Cholangitis 50
Oct 09, 2017: CymaBay Announces Oral Late-Breaking Presentation of Interim Results from an Ongoing Phase 2 Study of Patients with Primary Biliary Cholangitis at the AASLD 2017 Liver Meeting 51
Aug 15, 2017: CymaBay Therapeutics Announces the Publication of the Seladelpar Proof-of-Concept Study for Primary Biliary Cholangitis in Lancet Gastroenterology and Hepatology 52
Jul 17, 2017: CymaBay Announces Positive Interim Results from Its Ongoing Low-Dose Phase 2 Study of Seladelpar in Patients with Primary Biliary Cholangitis 53
Apr 13, 2017: CymaBay to Present Data from its Phase 2 Proof-of-Concept Study of Seladelpar in Patients With Primary Biliary Cholangitis at the EASL Liver Meeting 2017 54
Jan 05, 2017: CymaBay Therapeutics Announces Successful Completion of Scientific Advice Discussions with the European Medicines Agency for Arhalofenate 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CymaBay Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CymaBay Therapeutics Raises USD26.8 Million in Venture Financing 11
HistoIndex and CymaBay Therapeutics Enter into Partnership 12
CymaBay Therapeutics Raises USD114 Million in Public Offering of Shares 13
CymaBay Therapeutics Raises USD97 Million in Public Offering of Shares 15
CymaBay Therapeutics Raises USD10 Million in Public Offering of Shares 17
CymaBay Therapeutics Raises USD0.3 Million in Private Placement of Securities 18
CymaBay Therapeutics Raises USD23 Million in Public Offering of Shares 19
CymaBay Therapeutics Raises USD25.3 Million in Public Offering of Shares 21
CymaBay Therapeutics Completes Third Tranche Of Private Placement Of Shares For US$33.2 Million 23
CymaBay Therapeutics Inc, Key Competitors 24
CymaBay Therapeutics Inc, Key Employees 25
List of Figures
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CymaBay Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9